NEWS & MEDIA

Stemtek Therapeutics heading to the MassChallenge Article by the Spri Bizkaia talking about the three finalists from the "Bidge to MassChallenge": Gïk Live, Vostoc and Stemtek Therapeutics.   
New article in Cell Cycle that uses Cell2Sphere New article in Cell Cycle that uses our ready to us 3D cell culture solution, Cell2Spehre, as reference methodology to uncover novel therapeutic approaches in triple negative breast cancer.  Check it out!  
Bridge to MassChallenge Biscay 2017 winners   Stemtek Therapeutic´s CEO, Angel Garcia Martin, had the pleasure to be invited to participate in the Bridge to MassChalenge Biscay 2017, a boot camp that took place from March 20th to the 23rd at the MassChallenge´s flagship office in Boston, Massachusetts.   During this 4-day boot camp, all 12 selected entrepreneurs from the Basque Country and the representatives from BEAZ had the chance to attend amazing speaker...
Angel Garcia Martin interviewed on the podcast show “Health Policy Checkup” The True North President, Ron Lanton, speaks to Angel Garcia Martin, CEO of StemTek Therapeutics on the podcast show "Health Policy Checkup". During this interview they discuss: evolving cancer treatments, cancer stem cells, oncology drug development, as well as trends in the healthcare and pharmacy industry.  You may contact True North at info@truenorthps.com or fi...
Angel Garcia Martin interviewed on the radio show “Made in Basque Country” Andres Goñi interviewed Angel Garcia Martin, CEO of Stemtek Therapeutics, on the radio show “Made in Basque Country” where the top entrepreneurs from the Basque Country explain the latest innovations.           
Back to top